GlassScriptPhysician profile
Amber M Abraham
NPI 1598993297
$2,381.16
in general payments reported to CMS, 2019-2025
18 companies · $31.33 in 2025
The $31.33 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,028 · 2022: $1,137 · 2023: $185 · 2025: $31.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $392.79 | 2021-2022 | |
| Abbvie INC. | $381.51 | 2021-2022 | |
| Janssen Biotech, INC. | $318.96 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $290.26 | 2021-2023 | Dupixent |
| Lilly USA, LLC | $225.08 | 2021-2023 | Taltz, Olumiant |
| Genzyme Corporation | $152.03 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $126.20 | 2021-2022 | |
| Amgen INC. | $88.88 | 2021-2023 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $85.59 | 2022-2023 | Sotyktu |
| Pfizer INC. | $74.89 | 2021-2025 | |
| Vyne Pharmaceuticals INC. | $60.74 | 2021 | |
| Ucb, INC. | $51.57 | 2022 | |
| Dermavant Sciences, INC. | $35.16 | 2022-2023 | Vtama |
| Dermira, INC. | $24.05 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.38 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $21.99 | 2023 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.08 | 2021 | |
| Galderma Laboratories, L.P. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.